Kibow Biotech is a biotechnology company that has been operating since 1997 with its headquarters in the United States. The company specializes in the development and commercialization of scientifically-formulated and clinically-tested probiotic and prebiotic dietary supplements. Their products cater to various health needs, including kidney health, immunity support, cardiovascular health, digestive health, and overall wellness. Kibow Biotech's mission is to address health needs by leveraging their proprietary probiotics and functional fibers with extensive scientific and clinical validation to produce top-tier supplements. Their vision is to advance the welfare of people globally by providing superior probiotic supplements that are effective, safe, scientifically proven, economical, and convenient to use. The company has already developed several innovative products and aims to continue doing so while upholding their humanitarian and social values. Kibow Biotech is a promising player in the biotechnology industry, focusing on developing solutions that contribute to improving overall health and wellness. With their commitment to producing high-quality non-drug dietary supplements at affordable prices, the company is well-positioned to make a positive impact on the global health market. While specific investment details are currently unavailable, Kibow Biotech's dedication to addressing significant health risks and their innovative product development approach make them an intriguing prospect for potential venture capital interest.
There is no investment information
No recent news or press coverage available for Kibow Biotech .